Erythrocin and Cephalexin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Erythrocin (erythromycin lactobionate) and Cephalexin (cephalexin). Common drug interactions include palpitations among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Erythrocin and Cephalexin. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Erythrocin?

Erythrocin has active ingredients of erythromycin lactobionate. It is often used in tooth abscess. eHealthMe is studying from 1,200 Erythrocin users. Check the latest studies of Erythrocin.

What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 30,580 Cephalexin users. Check the latest studies of Cephalexin.



On Jul, 20, 2026

34 people who take Erythrocin and Cephalexin together, and have interactions are studied.

Erythrocin and Cephalexin drug interactions.

What are the common drug interactions of Erythrocin and Cephalexin, by gender? *:

female:

  1. Palpitations (feelings or sensations that your heart is pounding or racing)
  2. Periorbital oedema (swelling around the eyes)
  3. Pneumonia
  4. Pyelonephritis (inflammation of kidney caused by bacteria)
  5. Renal disorder (kidney disease)
  6. Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle)
  7. Type 2 diabetes mellitus
  8. Chronic kidney disease
  9. Renal failure (kidney dysfunction)
  10. Renal injury (kidney injury)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Hyperhidrosis (abnormally increased sweating)
  4. Hypokalaemia (low potassium)
  5. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  6. Occult blood positive
  7. Pain
  8. Palpitations (feelings or sensations that your heart is pounding or racing)
  9. Pneumonia
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Erythrocin and Cephalexin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Periorbital oedema (swelling around the eyes)

30-39:

  1. Complication of pregnancy

40-49:

  1. Chronic kidney disease

50-59:

  1. Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle)
  2. Type 2 diabetes mellitus
  3. Chronic kidney disease
  4. Renal failure (kidney dysfunction)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Dyspepsia (indigestion)
  7. Renal injury (kidney injury)
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Nephrogenic anaemia (anaemia due to kidney disease)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Diabetes mellitus inadequate control
  4. Emotional distress
  5. Hyperhidrosis (abnormally increased sweating)
  6. Hypokalaemia (low potassium)
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Occult blood positive
  9. Pain
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 55.88%
  2. Depression: 13 people, 38.24%
  3. Pain: 11 people, 32.35%
  4. High Blood Pressure: 9 people, 26.47%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 9 people, 26.47%
  6. Stress And Anxiety: 8 people, 23.53%
  7. High Blood Cholesterol: 8 people, 23.53%
  8. Cardiac Disorder: 8 people, 23.53%
  9. Cough: 8 people, 23.53%
  10. Nausea (feeling of having an urge to vomit): 7 people, 20.59%

* Approximation only. Some reports may have incomplete information.

Do you take Erythrocin and Cephalexin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Erythrocin and Cephalexin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Erythrocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cephalexin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Erythrocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cephalexin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on erythromycin lactobionate and cephalexin (the active ingredients of Erythrocin and Cephalexin, respectively), and Erythrocin and Cephalexin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: